| TOP PICK | | Fannie Mae | FNM-N | 68.710 | A pure value buy. 9 X trailing PE and 3% yield is intriguing. Headline risk is not as important as were the numbers and up ultimately. | 2004-04-30 | |
| TOP PICK | | Xerox | XRX-N | 13.430 | Betting on the franchise. Benefits from economic recovery on a global basis. Exciting product line with their iGen3. Still cheap. | 2004-04-30 | |
| BUY | | Abbott Labs | ABT-N | 44.020 | Attractive. Continuing turnaround in their diagnostic business as well as a better pipeline than some of the other chief pharmaceuticals. | 2004-04-30 | |
| BUY | | King Pharmaceuticals | KG-N | 17.250 | A potential takeover play. Has been a bit undermanaged and is very cheap. | 2004-04-30 | |
Rss Feed